FILANA THERAPEUTICS, INC. — Form 8-K
Filed September 18, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
Filana Therapeutics (public market value ~$87M) filed an 8-K on 2026-09-18 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing indicates the company has failed to meet continued listing requirements and faces potential transfer of listing or delisting. No specific dollar amounts, remediation timeline, or detailed reasons are disclosed in the filing header.
Why this rating
Delisting is existential risk for public company; threatens market access, valuation, fundraising. Material relative to $87M market cap.
Extracted items
Price action (we called it negative)
before filing · preread $0.73 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.